Chances are you already know us

Over the years, since our foundation in Japan in 1950, we have built a strong tradition of innovating, developing, manufacturing and marketing high-quality in vitro diagnostics testing solutions worldwide.

The acquisition of Centocor Diagnostics, CanAg Diagnostics and Innogenetics have further bolstered our capabilities and expertise in various clinical areas.

Today, working closely with one of the world’s top commercial laboratories (SRL, Inc.), another entity within the H.U. Group, Fujirebio combines expertise and experience for the diagnostics market that is more potent than ever.

Read about Fujirebio

Product categories:

Discover our solutions

 
 
 
 

Products by diseases and disorders:

Metabolic
Infectious Disease
Immune Response
Neurodegenerative
Oncology
Others

News & Events

View all news & upcoming events
15 Nov

NYS Neurological Society Annual Meeting 2025

New York City, United States of America
01 Dec

CTAD 2025

San Diego, United States of America
10 Feb

WHX Lab Dubai

Dubai, United Arab Emirates

Insights in the world of Fujirebio

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.